androstenedione has been researched along with Obesity, Morbid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Boughanem, H; Damas-Fuentes, M; Fernández-García, JC; Macías-González, M; Molina-Vega, M; Tinahones, FJ | 1 |
| Du, J; Ge, M; Mizraji, K; Niu, C; Segall-Gutierrez, P; Stanczyk, FZ; Tilley, I | 1 |
| Levit, CD; Miller, EH; Miller, LK; Rosenfeld, RS; Rosner, W; Strain, GW; Zumoff, B | 1 |
1 trial(s) available for androstenedione and Obesity, Morbid
| Article | Year |
|---|---|
Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women.
Topics: Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenedione; Biomarkers; Body Mass Index; Contraceptive Agents, Female; Dehydroepiandrosterone Sulfate; Drug Implants; Female; Humans; Medroxyprogesterone Acetate; Obesity; Obesity, Morbid; Sex Hormone-Binding Globulin; Subcutaneous Tissue; Testosterone; Time Factors; Young Adult | 2012 |
2 other study(ies) available for androstenedione and Obesity, Morbid
| Article | Year |
|---|---|
25-hydroxyvitamin D and testosterone levels association through body mass index: A cross-sectional study of young men with obesity.
Topics: Androstenedione; Body Mass Index; Cross-Sectional Studies; Gonadal Steroid Hormones; Humans; Male; Obesity, Morbid; Testosterone; Vitamin D | 2022 |
Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
Topics: Adult; Androstenedione; Dexamethasone; Estradiol; Estrone; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Obesity; Obesity, Morbid; Sex Hormone-Binding Globulin; Testosterone | 1988 |